Swift Transportation Company (NYSE:SWFT), a leader in transportation
solutions and the nation's largest truckload provider, has issued its
fourth quarter and year ended December 31, 2014 Letter to Stockholders.
Diodes Incorporated (Nasdaq: DIOD), a leading global manufacturer and
supplier of high-quality application specific standard products within
the broad discrete, logic and analog semiconductor markets, today
introduced chip-scale bi-directional MOSFETs.
By Shawn Langlois, MarketWatch Critical intelligence before the U.S. market opens
Back when the Dow was last trading under 7,000, you'd have to have been a bonafide nutjob to predict blue chips would hit the big, fat, round number of 18,000 in less than six years.
CNET Presents Its 13th Annual "The Next Big Thing" SuperSession on Augmented and Virtual Realities and Panels on the Smart Home and Connected Car Entrepreneurs Compete for a Chance at a "First Look" Video on CNET's Tech West Stage
SAN FRANCISCO , Jan.
Sign-up for CNET Brings CES 2015 To Consumers with Comprehensive Coverage of Top Show News and Tech Reviews, Live Video Streams of Major Press Conferences and CNET's "The Next Big Thing" SuperSession with Industry Innovators investment picks
NeuroMetrix, Inc. (Nasdaq: NURO) reported strong interest in Quell
coming out of last week’s Consumer Electronics Show (CES).
According to Frank McGillin, SVP and General Manager of Consumer Health
at NeuroMetrix, “In the first several days that the QuellRelief.com
website was live, we have had excellent traffic and an information
request signup rate of over 20%. This exceeds our original expectations
and reflects the need for a better solution for the over 100 million
Americans living with chronic pain.”
In the past week, Quell was featured in original stories in well over 30
media outlets including, C|NET, Forbes, PC Magazine, Bloomberg,
Drugstore News and MAC World.
In its annual outlook of global technology trends, Accenture (NYSE:ACN)
has identified a 180-degree shift to what it calls the “We Economy” that
is re-shaping markets and changing the way we work and live.
Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the International
Breast Cancer Study Group (IBCSG) presented results of the randomized
phase III SOFT clinical trial at the 2014 San Antonio Breast Cancer
Sign-up for Ipsen Announces That the International Breast Cancer Study Group (IBCSG) Presented Phase 3 Results Evaluating the Use of Ovarian Suppression to Adjuvant Treatment with Tamoxifen investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.